BAM
RXRX icon

Belpointe Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Belpointe Asset Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-244
Closed -$1.88K – 3836
2022
Q4 		$1.88K Buy
+244
New +$1.88K ﹤0.01% 3281